Osteogenesis Imperfecta Clinical Trial
— PaSOfficial title:
Pronti A Salpare: Studio di fattibilità Sull'Impatto Della Vela Come Ergoterapia in Pazienti Con Malattie Rare Scheletriche - Ready to Sail: Evaluating Sailing's Feasibility as Ergotherapy for Rare Skeletal Diseases
Verified date | May 2024 |
Source | Istituto Ortopedico Rizzoli |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background Individuals with rare skeletal disorders frequently experience psychological distress, social isolation, unmet needs, and significant challenges due to limited treatment options. Adventure Therapy, employing exposure to natural environments, has shown promise in improving self-esteem, autonomy, and social skills in chronic illness and disability populations. This pilot study explores the feasibility and preliminary efficacy of a sailing-based intervention for enhancing physical, social, and psychological well-being in this specific population. Outcome Measures The primary outcome is to investigates the feasibility of sailing to improve well-being and quality of life in patients living with rare skeletal disorders. Furthermore, the investigators hypothesize that participation in a sailing program led by occupational therapists will lead to improvements in: - Movement confidence: assessing whether sailing enhances participants' ability to move and perform daily activities. - Mental health: evaluating if sailing reduces anxiety and fear and promotes self-esteem. - Social interaction: exploring if sailing fosters social connection and reduces feelings of isolation. Methods The study will use a prospective, single-arm, longitudinal design. Eight participants with rare skeletal disorders will be enrolled in a 5-day sailing-based occupational therapy intervention. Comprehensive pre- and post-intervention assessments will measure psychosocial factors, quality of life, functional mobility, kinesiophobia, and body segment movement using questionnaires and functional scales.
Status | Active, not recruiting |
Enrollment | 8 |
Est. completion date | September 13, 2024 |
Est. primary completion date | September 13, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 12 Years and older |
Eligibility | Inclusion Criteria: - Individuals of any gender - Diagnosis of a rare skeletal disease, confirmed clinically and/or molecularly - Age 12 years or older - No history of surgery within six months prior to study enrollment. Exclusion Criteria: - Individuals undergoing diagnostic evaluation for a rare skeletal disease - Participants younger than 12 years of age. - Individuals who underwent surgery within the preceding 6 months. - Participants with fractures or musculoskeletal injuries sustained within the past year. - Individuals who were unable to provide written informed consent. |
Country | Name | City | State |
---|---|---|---|
Italy | IRCCS Istituto Ortopedico Rizzoli | Bologna |
Lead Sponsor | Collaborator |
---|---|
Istituto Ortopedico Rizzoli |
Italy,
Aprile I, Iacovelli C, Iuvone L, Imbimbo I, Cruciani A, Pecchioli C, Manozzi FM, Padua L. Use of a Virtual-Technological Sailing Program to Prepare Children With Disabilities for a Real Sailing Course: Effects on Balance and Quality of Life. J Child Neurol. 2016 Jul;31(8):1074-80. doi: 10.1177/0883073816638756. Epub 2016 Mar 28. — View Citation
Capurso, M.; Borsci, S. Effects of a Tall Ship Sail Training Experience on Adolescents' Self-Concept. International Journal of Educational Research 2013, 58, 15-24. https://doi.org/10.1016/j.ijer.2013.01.004.
Cornaglia Ferraris P. [Adventure therapy: principles, practice, perspectives.]. Recenti Prog Med. 2018 Oct;109(10):487-493. doi: 10.1701/3010.30086. Italian. — View Citation
Gill E, Goldenberg M, Starnes H, Phelan S. Outdoor adventure therapy to increase physical activity in young adult cancer survivors. J Psychosoc Oncol. 2016 May-Jun;34(3):184-99. doi: 10.1080/07347332.2016.1157718. Epub 2016 Mar 3. — View Citation
MacLachlan M. Sailing as an Intervention. In: MacLachlan M, editor. Maritime Psychology: Research in Organizational & Health Behavior at Sea. Cham: Springer International Publishing; 2017. https://doi.org/10.1007/978-3-319-45430-6_10
Recio AC, Becker D, Morgan M, Saunders NR, Schramm LP, McDonald JW 3rd. Use of a virtual reality physical ride-on sailing simulator as a rehabilitation tool for recreational sports and community reintegration: a pilot study. Am J Phys Med Rehabil. 2013 Dec;92(12):1104-9. doi: 10.1097/PHM.0000000000000012. — View Citation
Thompson T, Lamont-Robinson C, Williams V. At sea with disability! Transformative learning in medical undergraduates voyaging with disabled sailors. Med Educ. 2016 Aug;50(8):866-79. doi: 10.1111/medu.13087. — View Citation
Tracey D, Gray T, Truong S, Ward K. Combining Acceptance and Commitment Therapy With Adventure Therapy to Promote Psychological Wellbeing for Children At-Risk. Front Psychol. 2018 Aug 27;9:1565. doi: 10.3389/fpsyg.2018.01565. eCollection 2018. — View Citation
Zebrack B, Kwak M, Sundstrom L. First Descents, an adventure program for young adults with cancer: who benefits? Support Care Cancer. 2017 Dec;25(12):3665-3673. doi: 10.1007/s00520-017-3792-7. Epub 2017 Jun 27. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Health-related Quality of Life | EuroQol 5-Dimension (EQ-5D) instrument offers valuable information about patient-reported health status. EQ-5D assesses health status in terms of five dimensions of health, mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, and with EQ-5D visual analogue scale. It is considered a 'generic' questionnaire because these dimensions are not specific to any one patient group or health condition. | T0: Baseline | |
Primary | Health-related Quality of Life | EuroQol 5-Dimension (EQ-5D) instrument offers valuable information about patient-reported health status. EQ-5D assesses health status in terms of five dimensions of health, mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, and with EQ-5D visual analogue scale. It is considered a 'generic' questionnaire because these dimensions are not specific to any one patient group or health condition. | T1: up to 2 weeks | |
Primary | Health-related Quality of Life | EuroQol 5-Dimension (EQ-5D) instrument offers valuable information about patient-reported health status. EQ-5D assesses health status in terms of five dimensions of health, mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, and with EQ-5D visual analogue scale. It is considered a 'generic' questionnaire because these dimensions are not specific to any one patient group or health condition. | T2: up to 3 weeks | |
Primary | Health-related Quality of Life | EuroQol 5-Dimension (EQ-5D) instrument offers valuable information about patient-reported health status. EQ-5D assesses health status in terms of five dimensions of health, mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, and with EQ-5D visual analogue scale. It is considered a 'generic' questionnaire because these dimensions are not specific to any one patient group or health condition. | T3: up to 3 months | |
Primary | Information on the functioning and disability of an individual | The World Health Organisation Disability Assessment Schedule (WHODAS 2.0) is a standardized method for measuring health and disability by assessing the same individual before and after the intervention. WHODAS 2.0 is a 36-item questionnaire and captures the level of functioning in six domains of life: Cognition - understanding and communicating, Mobility - moving and getting around, Self-care - attending to one's hygiene, dressing, eating and staying alone, Getting along - interacting with other people, Life activities - domestic responsibilities, leisure, work and school, Participation - joining in community activities, participating in society. | T0: Baseline | |
Primary | Information on the functioning and disability of an individual | The World Health Organisation Disability Assessment Schedule (WHODAS 2.0) is a standardized method for measuring health and disability by assessing the same individual before and after the intervention. WHODAS 2.0 is a 36-item questionnaire and captures the level of functioning in six domains of life: Cognition - understanding and communicating, Mobility - moving and getting around, Self-care - attending to one's hygiene, dressing, eating and staying alone, Getting along - interacting with other people, Life activities - domestic responsibilities, leisure, work and school, Participation - joining in community activities, participating in society. | T3: up to 3 months | |
Secondary | Self-esteem | Rosenberg Self-Esteem Scale: 10-item scales, ranging from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem. | T0: Baseline | |
Secondary | Self-esteem | Rosenberg Self-Esteem Scale: 10-item scales, ranging from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem. | T1: up to 2 weeks | |
Secondary | Self-esteem | Rosenberg Self-Esteem Scale: 10-item scales, ranging from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem. | T2: up to 3 weeks | |
Secondary | Self-esteem | Rosenberg Self-Esteem Scale is a 10-item scale that assesses the self-esteem, ranging from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem. | T3: up to 3 months | |
Secondary | Motor coordination | Performance Oriented Mobility Assesment (Tinetti Balance Scale) is an administered 16-item task-oriented test that measures gait and balance abilities, it uses a 3-point ordinal scale of 0, 1 and 2. Gait is scored over 12 and balance is scored over 16 totalling 28. | T0: Baseline | |
Secondary | Motor coordination | Performance Oriented Mobility Assesment (Tinetti Balance Scale) is an administered 16-item task-oriented test that measures gait and balance abilities, it uses a 3-point ordinal scale of 0, 1 and 2. Gait is scored over 12 and balance is scored over 16 totalling 28. | T1: up to 2 weeks | |
Secondary | Motor coordination | Performance Oriented Mobility Assesment (Tinetti Balance Scale) is an administered 16-item task-oriented test that measures gait and balance abilities, it uses a 3-point ordinal scale of 0, 1 and 2. Gait is scored over 12 and balance is scored over 16 totalling 28. | T2: up to 3 weeks | |
Secondary | Motor coordination | Performance Oriented Mobility Assesment (Tinetti Balance Scale) is an administered 16-item task-oriented test that measures gait and balance abilities, it uses a 3-point ordinal scale of 0, 1 and 2. Gait is scored over 12 and balance is scored over 16 totalling 28. | T3: up to 3 months | |
Secondary | Balance | Berg Balance Scale is a 14-item objective measure that assesses static balance and fall risk, item-level scores range from 0-4, determined by ability to perform the assessed activity, the item scores are then summed with a maximum of 56. | T0: Baseline | |
Secondary | Balance | Berg Balance Scale is a 14-item objective measure that assesses static balance and fall risk, item-level scores range from 0-4, determined by ability to perform the assessed activity, the item scores are then summed with a maximum of 56. | T1: up to 2 weeks | |
Secondary | Balance | Berg Balance Scale is a 14-item objective measure that assesses static balance and fall risk, item-level scores range from 0-4, determined by ability to perform the assessed activity, the item scores are then summed with a maximum of 56. | T2: up to 3 weeks | |
Secondary | Balance | Berg Balance Scale is a 14-item objective measure that assesses static balance and fall risk, item-level scores range from 0-4, determined by ability to perform the assessed activity, the item scores are then summed with a maximum of 56. | T3: up to 3 months | |
Secondary | Kinesiophobia | Tampa Scale is a self-reported questionnaire that quantifies fear of movement, or (re)injury, it uses a 4-point Likert scale (Strongly Disagree-Disagree-Agree-Strongly Agree) with statements that have been later linked to the model of fear-avoidance, fear of work-related activities, fear of movement, and fear of re-injury. | T0: Baseline | |
Secondary | Kinesiophobia | Tampa Scale is a self-reported questionnaire that quantifies fear of movement, or (re)injury, it uses a 4-point Likert scale (Strongly Disagree-Disagree-Agree-Strongly Agree) with statements that have been later linked to the model of fear-avoidance, fear of work-related activities, fear of movement, and fear of re-injury. | T1: up to 2 weeks | |
Secondary | Kinesiophobia | Tampa Scale is a self-reported questionnaire that quantifies fear of movement, or (re)injury, it uses a 4-point Likert scale (Strongly Disagree-Disagree-Agree-Strongly Agree) with statements that have been later linked to the model of fear-avoidance, fear of work-related activities, fear of movement, and fear of re-injury. | T2: up to 3 weeks | |
Secondary | Kinesiophobia | Tampa Scale is a self-reported questionnaire that quantifies fear of movement, or (re)injury, it uses a 4-point Likert scale (Strongly Disagree-Disagree-Agree-Strongly Agree) with statements that have been later linked to the model of fear-avoidance, fear of work-related activities, fear of movement, and fear of re-injury. | T3: up to 3 months | |
Secondary | Well-being and Mental Health | Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) is a self-report measure of psychological distress designed to be administered during a course of treatment to determine treatment response. It compries 34 questions about how the participants have been feeling over the last week, using a 5-point scale. The scale covers four dimensions: Subjective well-being, Problems/symptoms, Life functioning, and Risk/harm. | T0: Baseline | |
Secondary | Well-being and Mental Health | Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) is a self-report measure of psychological distress designed to be administered during a course of treatment to determine treatment response. It compries 34 questions about how the participants have been feeling over the last week, using a 5-point scale. The scale covers four dimensions: Subjective well-being, Problems/symptoms, Life functioning, and Risk/harm. | T1: up to 2 weeks | |
Secondary | Well-being and Mental Health | Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) is a self-report measure of psychological distress designed to be administered during a course of treatment to determine treatment response. It compries 34 questions about how the participants have been feeling over the last week, using a 5-point scale. The scale covers four dimensions: Subjective well-being, Problems/symptoms, Life functioning, and Risk/harm. | T2: up to 3 weeks | |
Secondary | Well-being and Mental Health | Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) is a self-report measure of psychological distress designed to be administered during a course of treatment to determine treatment response. It compries 34 questions about how the participants have been feeling over the last week, using a 5-point scale. The scale covers four dimensions: Subjective well-being, Problems/symptoms, Life functioning, and Risk/harm. | T3: up to 3 months | |
Secondary | Physical functioning and psychological well-being | Pediatric Outcomes Data Collection (PODCI) evaluates functional health status through an 83-item questionnaire, and consists of scores on seven core scales, four encompassing physical function and three assessing psychological well-being. | T0: Baseline | |
Secondary | Physical functioning and psychological well-being | Pediatric Outcomes Data Collection (PODCI) evaluates functional health status through an 83-item questionnaire, and consists of scores on seven core scales, four encompassing physical function and three assessing psychological well-being. | T1: up to 2 weeks | |
Secondary | Physical functioning and psychological well-being | Pediatric Outcomes Data Collection (PODCI) evaluates functional health status through an 83-item questionnaire, and consists of scores on seven core scales, four encompassing physical function and three assessing psychological well-being. | T2: up to 3 weeks | |
Secondary | Physical functioning and psychological well-being | Pediatric Outcomes Data Collection (PODCI) evaluates functional health status through an 83-item questionnaire, and consists of scores on seven core scales, four encompassing physical function and three assessing psychological well-being. | T3: up to 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03557567 -
NGS Strategy Effectiveness in Molecular Diagnosis
|
||
Not yet recruiting |
NCT05559801 -
Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02531087 -
Urinary Biomarkers of OI Pathobiology
|
||
Completed |
NCT01713231 -
Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta
|
Phase 4 | |
Completed |
NCT00655681 -
Prevention of Post Operative Bone Loss in Children
|
N/A | |
Recruiting |
NCT06065111 -
Study of Osteogenesis Imperfecta Tendon
|
||
Withdrawn |
NCT03216486 -
An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta
|
Phase 2 | |
Recruiting |
NCT06086613 -
A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04009733 -
Epigenetic Regulation of Osteogenesis Imperfecta Severity : miROI Study
|
N/A | |
Completed |
NCT04231916 -
High Resolution Thermal Imaging to Identify Vertebral Fractures in Children and Young People With Osteogenesis Imperfecta
|
N/A | |
Active, not recruiting |
NCT02814591 -
Development of a Non-invasive Assessment of Human Bone Quality Using Spatially Offset Raman Spectroscopy
|
||
Completed |
NCT00982124 -
An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta
|
Phase 3 | |
Completed |
NCT00001305 -
Growth Hormone Therapy in Osteogenesis Imperfecta
|
Phase 3 | |
Completed |
NCT04119388 -
Evaluation of the Benefits of Adaptive Physical Activity in Children and Adolescents With Osteogenesis Imperfecta
|
N/A | |
Terminated |
NCT01679080 -
The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta
|
Phase 2 | |
Completed |
NCT00106028 -
Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children
|
Phase 3 | |
Recruiting |
NCT04152551 -
Effects of Bisphosphonates on OI-Related Hearing Loss
|
Phase 4 | |
Completed |
NCT00705120 -
Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation
|
Phase 1 | |
Recruiting |
NCT04169568 -
Osteogenesis Imperfecta Blood Pressure Study
|
||
Completed |
NCT03064074 -
Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta
|
Phase 1 |